01
Agents work the queue
Agents handle portal work, corrections, calls, and follow-up so claims keep moving.
Oncology only. No recovery, no fee.
Stop losing $1.3M
to denied claims.
One practice. Five months. Underpayments alone.
You can't lose money on this.
Oncology and infusion practices
AI-native recovery
AI works the queue. Experts handle the edge cases.
Every claim takes the same path. Agents carry the volume, RCM specialists take the judgment calls, and each outcome sharpens the queue that comes next.
Active recovery queue
- CO-197Auth expired$18,400
- CO-50Medical necessity$11,250
- N569J-code correction$7,920
- P12ASP variance$4,610
Evidence assembled per claim
Payer policyClinical recordPortal action
02
RCM experts govern the edge cases
Specialists review high-dollar appeals, policy exceptions, and payer-specific arguments.
03
The system learns by payer
Outcomes feed the next queue so timing, evidence, and appeals get sharper by payer.
The oncology math
One denial wipes out twenty paid claims.
Oncology runs buy-and-bill: you pay cash for the drug before the claim ever goes out. Medicare reimburses ASP plus 6% — about 4.3% after sequestration. So a denial doesn't cost you the profit. It costs you the drug.
~$14,000
average denied claim in oncology
30–40%
of oncology denials caused by authorization gaps
4.3%
effective margin on Part B drugs after sequestration
Recovery estimate
Three numbers. One fast estimate.
Move the sliders to see what a year of denied infusion claims is worth to your practice.
Estimated annual recovery
$1,058,400
At risk
$3,024,000
Per month
$88,200
Estimate only. No PHI. A real audit replaces this with remit, payer, NDC, and filing-deadline data.
Request auditEnd-to-end recovery
Claims you can't reach.Dievra works the claims your current workflows cannot reach.
CO-197
Auth lapsesAuthorization lapse recovery
Caught before it lapses
Treatment-level auth tracking with renewal triggers two cycles before expiration. The highest-dollar denial category, caught before it happens.
P12
ASP gapsASP underpayment detection
Checked against ASP
Every drug payment reconciled against the current quarter's ASP schedule. Underpayments are invisible in denial reports. We find them.
N569
J-code fixesJ-code claim correction
Units, NDC, modifiers
Unit calculations, NDC crosswalks, JW/JZ modifiers, and CPT administration pairings validated against HCPCS descriptors.
CO-50
AppealsAppeals worked to outcome
Worked to outcome
Not drafted and forgotten. Pursued through payer portals, phone queues, and escalation until resolved.
Oncology only
Pay only on recovery
No cherry-picking
SOC 2 + HIPAA
Oncology only
Pay only on recovery
No cherry-picking
SOC 2 + HIPAA
Oncology only
Pay only on recovery
No cherry-picking
SOC 2 + HIPAA
Claims review, together
Human judgment where it matters most.
Revenue risk
Know what is worth working first.
Dievra turns remits into a short, human-ready recovery list.
How it works
What if claims actually kept moving?
01.
Connect
We integrate with your practice management and EHR system.
02.
Audit
We run twelve months of remits against ASP schedules and hand you a number before you commit.
03.
Work
AI agents pursue each claim through portals, corrections, and appeals.
04.
Recover
Payment posts to you. We invoice a percentage of what came back.
Request demo
Request a focused recovery demo.
Pick the conversation you want to have — a twelve-month recovery audit, a dashboard walkthrough, or an integration review. We show only the workflow and claim logic relevant to that path.
Request demo
No PHI required. Takes about a minute.